Candidal costochondritis responsive to ketoconazole in an IV drug abuser

B. P. Grubb, M. M. Manders, C. A. Haile

Research output: Contribution to journalArticle

Abstract

Infections caused by Candida albicans have been reported in many organ systems in intravenous drug users. Amphotericin B (Fungizone) has been shown to be effective in treatment. However, because of its numerous side effects and difficulty in maintaining intravenous access in this population, the agent is difficult to use. Ketoconazole (Nizoral), administered orally, is a more convenient and better tolerated agent and was efficacious in the case of candidal costochondritis described here. Further evaluation of ketoconazole is needed to better define its role in the treatment of disseminated candidiasis, particularly in cases associated with intravenous drug abuse.

Original languageEnglish (US)
JournalPostgraduate Medicine
Volume79
Issue number7
StatePublished - 1986
Externally publishedYes

Fingerprint

Ketoconazole
Drug Users
Amphotericin B
Intravenous Substance Abuse
Candidiasis
Candida albicans
Therapeutics
Infection
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Grubb, B. P., Manders, M. M., & Haile, C. A. (1986). Candidal costochondritis responsive to ketoconazole in an IV drug abuser. Postgraduate Medicine, 79(7).

Candidal costochondritis responsive to ketoconazole in an IV drug abuser. / Grubb, B. P.; Manders, M. M.; Haile, C. A.

In: Postgraduate Medicine, Vol. 79, No. 7, 1986.

Research output: Contribution to journalArticle

Grubb, BP, Manders, MM & Haile, CA 1986, 'Candidal costochondritis responsive to ketoconazole in an IV drug abuser', Postgraduate Medicine, vol. 79, no. 7.
Grubb, B. P. ; Manders, M. M. ; Haile, C. A. / Candidal costochondritis responsive to ketoconazole in an IV drug abuser. In: Postgraduate Medicine. 1986 ; Vol. 79, No. 7.
@article{d9db39e304d34dc49abb91eddaefada2,
title = "Candidal costochondritis responsive to ketoconazole in an IV drug abuser",
abstract = "Infections caused by Candida albicans have been reported in many organ systems in intravenous drug users. Amphotericin B (Fungizone) has been shown to be effective in treatment. However, because of its numerous side effects and difficulty in maintaining intravenous access in this population, the agent is difficult to use. Ketoconazole (Nizoral), administered orally, is a more convenient and better tolerated agent and was efficacious in the case of candidal costochondritis described here. Further evaluation of ketoconazole is needed to better define its role in the treatment of disseminated candidiasis, particularly in cases associated with intravenous drug abuse.",
author = "Grubb, {B. P.} and Manders, {M. M.} and Haile, {C. A.}",
year = "1986",
language = "English (US)",
volume = "79",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "7",

}

TY - JOUR

T1 - Candidal costochondritis responsive to ketoconazole in an IV drug abuser

AU - Grubb, B. P.

AU - Manders, M. M.

AU - Haile, C. A.

PY - 1986

Y1 - 1986

N2 - Infections caused by Candida albicans have been reported in many organ systems in intravenous drug users. Amphotericin B (Fungizone) has been shown to be effective in treatment. However, because of its numerous side effects and difficulty in maintaining intravenous access in this population, the agent is difficult to use. Ketoconazole (Nizoral), administered orally, is a more convenient and better tolerated agent and was efficacious in the case of candidal costochondritis described here. Further evaluation of ketoconazole is needed to better define its role in the treatment of disseminated candidiasis, particularly in cases associated with intravenous drug abuse.

AB - Infections caused by Candida albicans have been reported in many organ systems in intravenous drug users. Amphotericin B (Fungizone) has been shown to be effective in treatment. However, because of its numerous side effects and difficulty in maintaining intravenous access in this population, the agent is difficult to use. Ketoconazole (Nizoral), administered orally, is a more convenient and better tolerated agent and was efficacious in the case of candidal costochondritis described here. Further evaluation of ketoconazole is needed to better define its role in the treatment of disseminated candidiasis, particularly in cases associated with intravenous drug abuse.

UR - http://www.scopus.com/inward/record.url?scp=0022475686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022475686&partnerID=8YFLogxK

M3 - Article

C2 - 3703772

AN - SCOPUS:0022475686

VL - 79

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 7

ER -